Alector Inc (NASDAQ:ALEC)
| 16.85 Delayed Data As of Jan 15 |  +1.31 / +8.43%Today’s Change | 9.12 Today|||52-Week Range 35.93 | +11.37% Year-to-Date |
Latest ALEC News | Press Releases
No recent news for Alector Inc.
Today’s Trading
| Previous close | 15.54 |
| Today’s open | 15.45 |
| Day’s range | 15.29 - 17.12 |
| Volume | 25,984 |
| Average volume (3 months) | 779,293 |
| Market cap | $1.3B |
Data as of 4:00pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | -127.92% |
| Earnings growth (this year) | -42.36% |
| Earnings growth (next 5 years) | +6.84% |
| Revenue growth (last year) | -23.33% |
| P/E ratio | NM |
| Price/Sales | 50.13 |
| Price/Book | 5.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CHRSCoherus BioSciences ... | -0.29 | -1.61% |
| IMGNImmunoGen Inc | -0.38 | -5.01% |
| TVTXTravere Therapeutics... | -1.36 | -4.67% |
| BTAIBioXcel Therapeutics... | -2.68 | -4.95% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Next reporting date | March 30, 2021 |
| EPS forecast (this quarter) | -$0.65 |
| Annual revenue (last year) | $21.2M |
| Annual profit (last year) | -$105.4M |
| Net profit margin | -496.65% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
